Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy.
The efficacy of ofloxacin in preventing infection in neutropenic patients following cytotoxic chemotherapy was evaluated and was compared with that of co-trimoxazole. A total of 102 patients with hematological malignancies were randomly selected to receive either co-trimoxazole or ofloxacin. All pat...
Збережено в:
| Опубліковано в:: | Antimicrob Agents Chemother |
|---|---|
| Автори: | , , , , , , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
American Society for Microbiology (ASM)
1990
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171559/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2327768/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.2.215 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
